World's biggest vaccine maker, Pune based Serum Institute of India (SII) is set to sign the deal with the Government of India to supply vaccines ar a fixed price of Rs 250 per dosage, Business Standard.
SII has already applied for the emergency use authorisation (EUA) of the Covishield vaccine candidate developed by the University of Oxford and pharmaceutical giant AstraZeneca and is likely to now conclude a supply contract with the Government which is presently in final stages.
Also, it is likely that by March-April 2021, SII's Covishield vaccine will also be available in the private markets. Company's chief executive Adar Poonawalla had earlier indicated that the price of the vaccine in the private markets could be around Rs 500-600 per dosage.
Meanwhile, SII is likely to supply the Government with a bulk of the 400-600 million dosages which will be needed by the government in the initial phases up to July. However, it should be noted that the size of the supply contract between SII and the Government is not known yet. It is expected that by January-February, SII could have at least 100 million doses for the Government.
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 999/year is the best way you can support our efforts.